DE68910159T2 - Dosierform für Verabreichung in der Humanmedizin. - Google Patents

Dosierform für Verabreichung in der Humanmedizin.

Info

Publication number
DE68910159T2
DE68910159T2 DE89300048T DE68910159T DE68910159T2 DE 68910159 T2 DE68910159 T2 DE 68910159T2 DE 89300048 T DE89300048 T DE 89300048T DE 68910159 T DE68910159 T DE 68910159T DE 68910159 T2 DE68910159 T2 DE 68910159T2
Authority
DE
Germany
Prior art keywords
administration
dosage form
human medicine
delivering
environment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89300048T
Other languages
English (en)
Other versions
DE68910159D1 (de
Inventor
Joseph C Deters
Felix Theeuwes
Patrick S-L Wong
David R Swanson
Brian A Barclay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE68910159D1 publication Critical patent/DE68910159D1/de
Application granted granted Critical
Publication of DE68910159T2 publication Critical patent/DE68910159T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DE89300048T 1988-03-21 1989-01-05 Dosierform für Verabreichung in der Humanmedizin. Expired - Lifetime DE68910159T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/173,524 US4837111A (en) 1988-03-21 1988-03-21 Dosage form for dispensing drug for human therapy

Publications (2)

Publication Number Publication Date
DE68910159D1 DE68910159D1 (de) 1993-12-02
DE68910159T2 true DE68910159T2 (de) 1994-02-17

Family

ID=22632422

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89300048T Expired - Lifetime DE68910159T2 (de) 1988-03-21 1989-01-05 Dosierform für Verabreichung in der Humanmedizin.

Country Status (12)

Country Link
US (1) US4837111A (de)
EP (1) EP0334465B1 (de)
JP (1) JP2729072B2 (de)
AT (1) ATE96308T1 (de)
CA (1) CA1315687C (de)
DE (1) DE68910159T2 (de)
DK (1) DK175637B1 (de)
ES (1) ES2045400T3 (de)
HK (1) HK1003980A1 (de)
IE (1) IE62131B1 (de)
MX (1) MX9203554A (de)
PT (1) PT90049B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5002540A (en) * 1989-05-22 1991-03-26 Warren Kirschbaum Intravaginal device and method for delivering a medicament
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
GB9101502D0 (en) * 1991-01-23 1991-03-06 Controlled Therapeutics Sct Controlled release compositions
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
US5226902A (en) * 1991-07-30 1993-07-13 University Of Utah Pulsatile drug delivery device using stimuli sensitive hydrogel
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5266332A (en) * 1991-12-06 1993-11-30 Alza Corporation Method for administering anti-Parkinson drug
US5254349A (en) * 1991-12-06 1993-10-19 Alza Corporation Process for lessening irritation caused by drug
US5531734A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Method of altering composition of nutritional product during enteral tube feeding
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
US6309373B1 (en) 1998-08-12 2001-10-30 Abbott Laboratories Apparatus for altering the characteristics of a fluid
US6264695B1 (en) * 1999-09-30 2001-07-24 Replication Medical, Inc. Spinal nucleus implant
ATE318846T1 (de) * 1999-11-12 2006-03-15 Macromed Inc An- und abschwellende polymermischungen
US6537584B1 (en) 1999-11-12 2003-03-25 Macromed, Inc. Polymer blends that swell in an acidic environment and deswell in a basic environment
CA2395231C (en) 1999-12-23 2006-08-15 Pfizer Products Inc. Hydrogel-driven layered drug dosage form
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
DK1411899T3 (da) * 2001-08-01 2009-06-02 Novartis Ag Smagsmaskerende sammensætning
KR100453288B1 (ko) * 2002-03-12 2004-10-21 한국화학연구원 약물의 제어 방출을 위한 스퀴즈-유형의 삼투성 약물 전달장치
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device
EP1824491A1 (de) * 2004-11-22 2007-08-29 Ranbaxy Laboratories Limited Osmotisch kontrolliertes monokompartiment-abgabesystem für doxazosin
US20080039473A1 (en) * 2006-08-08 2008-02-14 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
CN101439026B (zh) * 2007-11-23 2011-04-06 北京红林制药有限公司 含有多沙唑嗪或其盐的控释制剂及其制备方法
CN109589491B (zh) * 2019-01-29 2024-01-09 上海安翰医疗技术有限公司 自动给药装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4188390A (en) 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4760057A (en) * 1983-06-23 1988-07-26 Merck & Co., Inc. (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
EP0253554A3 (de) * 1986-07-15 1988-07-20 Pfizer Inc. Arzneihaltige Fasern mit verzögerter Freisetzung
US4758569A (en) * 1987-08-26 1988-07-19 Pfizer Inc. Doxazosin as an anti-atherosclerosis agent

Also Published As

Publication number Publication date
ATE96308T1 (de) 1993-11-15
US4837111A (en) 1989-06-06
JPH01242528A (ja) 1989-09-27
ES2045400T3 (es) 1994-01-16
PT90049B (pt) 1995-03-01
DK175637B1 (da) 2005-01-03
IE62131B1 (en) 1994-12-14
HK1003980A1 (en) 1998-11-13
DK135389D0 (da) 1989-03-20
JP2729072B2 (ja) 1998-03-18
DE68910159D1 (de) 1993-12-02
EP0334465B1 (de) 1993-10-27
IE890142L (en) 1989-09-21
DK135389A (da) 1989-09-22
PT90049A (pt) 1989-11-10
MX9203554A (es) 1992-09-01
CA1315687C (en) 1993-04-06
EP0334465A1 (de) 1989-09-27

Similar Documents

Publication Publication Date Title
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
NO920740L (no) Doseringsform for oral administrering av hypoglykemisk glipizid
NO306377B1 (no) Doseform for avgivelse av et medikament
DK567088D0 (da) Indretning til transdermal laegemiddelindgift
ATE142116T1 (de) Durch körperliche aktivität gesteuerte vorrichtung zur iontophoretischen verabreichung von medikamenten
FI103180B (fi) Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehd usten torjumiseksi eläimissä ja ihmisissä
DK156375C (da) Praeparater til oral administration til droevtyggere med langvarig medikamentafgivelse
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
YU49390A (sh) Postupak za izradu transdermalnog terapijskog sistema sa stupnjevitim otpuštanjem aktivne materije
ES2043744T3 (es) Sistema de suministro transdermico de procaterol.
ATE59550T1 (de) Chlorpheniramine therapie.
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
GB1547562A (en) Guns eg for use in the administration of drugs or medicines to animals
IT1214915B (it) Derivato dell'acido 4-metossiisoftalico con attivita'farmacologica in disordini tromboembolici e procedimento per la sua preparazione
NO873805L (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
ES2052467T1 (es) Preparaciones farmaceuticas de alfa-dihidroergocriptina con actividad neuroprotectora.
DK467586D0 (da) Medicindoseringsapparat for afgivelse af forstaevet medicin til inhaleringsluft
IT1219938B (it) Impiego farmaceutico del dietila-minoetil-destrano

Legal Events

Date Code Title Description
8364 No opposition during term of opposition